How can we help?
$60.00
Gain knowledge about the plant origin of CBD and THC and an understanding of the metabolism profile for CBD in urine. This session will examine the effect of CBD on workplace drug testing and the impact of Delta-8-THC on marijuana confirmations for Delta 9-THCA.
Dr. David Kuntz, Executive Director for Analytical Toxicology/Laboratory Director Clinical Reference Laboratories
Member price: $50
$60 for non-members
After purchase, you will receive access to a link that allows you to download the video file for this recorded session. The link expires after 60 days.
Search this site
Stay in touch
Give to NDASA
Invest in safe and drug-free communities and workplaces and support NDASA.
Latest News & Updates
- Nov 09, 2021Marijuana Impairment and Drug Testing
- Oct 22, 2021Exceptions to Recent New York Guidance Restricting Workplace Testing for Marijuana
- Oct 15, 2021Introducing the NDASA University Network Partnership Program for Members
- Oct 02, 2021What is an EAP?
- Sep 27, 2021NDASA Member Update: A Word from our Leadership
Topics We Track
- Committee Reports (1)
- DOT (4)
- Drug & Alcohol Testing (13)
- Drug Legislation (6)
- Feature (38)
- FMCSA (3)
- For Drug Testing Industry Professionals (14)
- For Employers and Workplace Safety & Wellness Professionals (12)
- Industry News (6)
- Marijuana & CBD (13)
- Member Benefits (1)
- Membership (2)
- NDASA Conference (6)
- NDASA Guidance (2)
- Opioids (2)
- Resources (21)
- Substance Use (1)
- Substance Use/Addiction (2)
- Training (1)
- Uncategorized (6)
- Workplace Safety (1)